Important information from the Federal Office for Public Health Safety on the new withdrawal period for veterinary medicinal products containing Toltrazuril for oral administration to chickens.
Up-to-date information from the November 12.12.-15.12.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that a male offspring of donor-25203 MUGGIE-has been diagnosed with global developmental delay, decreased liver function, and abnormal glycosylation.
The Federal Office relies on reports from consumers, health care professionals and companies for the continuous re-evaluation of the safety profile of medicinal products and medical devices.
The medicinal products database contains all products authorised in Austria, including up-to-date product information leaflets and the summary of products characteristics.
This is the subpage with information from the BASG directed to health care professionals (physicians, dentists, veterinarians, midwives and pharmacists).